Phaseline

Companies › Fertility Center of Las Vegas

Fertility Center of Las Vegas: clinical trials, targets and expected readouts

1 active drug program in 1 registered trial: 1 Phase 4; Genitourinary; next expected readout Dec 2027.

Open in Phaseline: competitors, likelihood bands and readouts Company report

Programs

DrugTargetHighest phaseConditionsNext expected readout
hCG injection
human chorionic gonadotropin - luteal phase support
CGA, CGBPhase 4Infertility (IVF Patients)Dec 2027

Trials

Registry idDrugPhaseConditionsAreaExpected readout
NCT07004192hCG injectionPhase 4Infertility (IVF Patients)GenitourinaryDec 2027

Targets

CGA (1) CGB (1)

Companies with the same targets

–

Companies built like this

Zydus Lifesciences Granata Bio Dimerix Bioscience Chengdu Qingshan Likang Pharmaceutical Hope Medicine (Nanjing)

Pipelines of the same shape: areas, drug types, target families, stage and cash runway.

Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.